FDA 483 - Therapak Corporation - February 12, 2026
Discuss this record with AI
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.
An FDA inspection of Therapak Corporation, a contract manufacturer in Claremont, CA, revealed significant deficiencies in their quality management system. The firm failed to properly utilize data analysis for improvement, specifically demonstrating erroneous statistical sampling for both receiving inspection and manufacturing of medical devices. Additionally, procedures for the feedback process, particularly regarding complaint handling and risk categorization, were found to be undocumented or improperly applied.
ID · 93e788d2-6c1e-452f-a54b-45c9720682d4